Tanaka Yoshimichi

タナカヨシミチ | Tanaka Yoshimichi

Affiliation and department：
Job title： Associate professor
Research theme for competitive and other funds (26)：

2022 - 2025 卵巣癌再発・転移に対して硼素中性子捕捉療法の有用性の検討
2022 - 2025 硼素中性子捕捉療法とLAT1を介した化学療法を併用する子宮頸癌の新たな治療戦略
2022 - 2025 癌特異的EVs内のmiRNAをターゲットとした腫瘍免疫システムの機序解明
2021 - 2024 卵巣癌オルガノイドを用いた脂肪細胞によるがん浸潤・転移機構の解明
2020 - 2023 3次元オルガノイド培養を用いた難治性卵巣癌の個別化医療の構築

2019 - 2022 複合的癌免疫治療による子宮頚癌治療の革新的開発

2019 - 2022 Analysis of extracellular vesicles using patient derived xenograft

2018 - 2021 Target therapy of ovarian cancer including immunotherapy via Eribulin

2017 - 2020 Research for cancer microenvironment via FABP4 in endometrial cnacer

2017 - 2020 Development of a new therapy for refractory ovarian cancer via liposomal nanoparticle targeting control of EMT

2017 - 2020 Treatment strategy of boron neutron capture therapy in cervical cancer

2016 - 2019 A novel miRNA regulates the EMT and MMT of peritoneal mesothelium in ovarian cancer

2016 - 2019 A novel approach for cervical cancer using exosome

2016 - 2019 Analysis of lipid raft via CD24 and drug resistance in gynecologic cancer

2015 - 2018 Testosterone for the Prevention of Cyclophosphamide -Induced Ovarian Toxicity

2015 - 2018 GPR30 signaling regulates Epithelial-Mesenchymal Transition in ovarian cancer

2014 - 2017 The elucidation of the mechanism in cancer microenvironment by ovarian cancer secretion exosome and the development of a next-generation cancer therapy by the exosome.

2014 - 2016 analysis of a new endogenous protein in endometrial cancer

2013 - 2016 Elucidation of novel molecules involved in the MET and disseminated in ovarian cancer peritoneal metastasis

2013 - 2016 Potential therapeutic target of microRNA in cervical cancer.

2013 - 2016 CD24-targeting drug delivery system enhanced effect of cisplatin-resistant ovarian cancer cells

2013 - 2016 Development of anticancer drug resistance evaluation system, and early recurrence-detection tools in ovarian cancer

2012 - 2015 Control of EMT phenomenon by mTOR inhiibitor for ovarian clear cell carcinoma.

2012 - 2015 Fibrates protect against vascular endothelial dysfunction induced by paclitaxel and carboplatin chemotherapy for cancer patients: a pilot study.

2012 - 2015 To control in invasion and metastasis through EMT (Epithelial-Mesenchymal-Transition) functional analysis of CD24 in endometrial cancer

2012 - 2014 CD24 expression is correlated with an EMT (Epithelial-Mesenchymal-Transition) status in endometrial cancer

Show all

Papers (32)：

Shinichi Terada, Satoshi Tsunetoh, Yoshimichi Tanaka, Tomohito Tanaka, Hideki Kashiwagi, Takushi Takata, Shinji Kawabata, Minoru Suzuki, Masahide Ohmichi. Boron uptake of boronophenylalanine and the effect of boron neutron capture therapy in cervical cancer cells. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine. 2023. 197. 110792-110792
Kosuke Hiramatsu, Yutaka Ueda, Asami Yagi, Akiko Morimoto, Tomomi Egawa-Takata, Satoshi Nakagawa, Eiji Kobayashi, Toshihiro Kimura, Tadashi Kimura, Ryoko Minekawa, et al. The efficacy of human papillomavirus vaccination in young Japanese girls: the interim results of the OCEAN study. Human vaccines & immunotherapeutics. 2022. 18. 1. 1951098-1951098
Shinichi Terada, Yoshito Terai, Yoshimichi Tanaka, Tomohito Tanaka, Satoshi Tsunetoh, Masahide Ohmichi. Postsurgical urodynamic study of total laparoscopic nerve-sparing radical hysterectomy for uterine cervical cancer. The journal of obstetrics and gynaecology research. 2022. 48. 11. 2863-2871
Hiromi Konishi, Tomohito Tanaka, Hiroshi Maruoka, Yuhei Kogata, Satoe Fujiwara, Yoshimichi Tanaka, Kohei Taniguchi, Kazumasa Komura, Masami Hayashi, Masahide Ohmichi. Reproductive outcomes after radical abdominal trachelectomy for cervical cancer. European Journal of Gynaecological Oncology. 2021. 42. 4. 688-693
Satoe Fujiwara, Ruri Nishie, Shoko Ueda, Syunsuke Miyamoto, Shinichi Terada, Yuhei Kogata, Tomohito Tanaka, Yoshimichi Tanaka, Masahide Ohmichi. Prognostic significance of peritoneal cytology in low-risk endometrial cancer: comparison of laparoscopic surgery and laparotomy. International journal of clinical oncology. 2021. 26. 4. 777-783

ｍore...

MISC (294)：

飯藤宰士, 藤田太輔, 古形祐平, 寺田信一, 田中良道, 田中智人, 恒遠啓示, 山田隆司, 大道正英. A case of hepatic endometriosis with previous laparoscopic surgery. 産婦人科の進歩. 2022. 74. 3. 351-359
寺田信一, 西江瑠璃, 上田尚子, 橋田宗祐, 宮本瞬輔, 古形祐平, 藤原聡枝, 田中良道, 田中智人, 恒遠啓示, et al. 当院における子宮体癌に対するセンチネルリンパ節生検の検討. 日本婦人科腫瘍学会学術講演会プログラム・抄録集. 2022. 64回. 189-189
上田尚子, 西江瑠璃, 橋田宗祐, 宮本瞬輔, 寺田信一, 古形祐平, 藤原聡枝, 田中良道, 田中智人, 大道正英. 子宮体がんにおける個別化治療にむけたPDXモデルの検討. 日本婦人科腫瘍学会学術講演会プログラム・抄録集. 2022. 64回. 195-195
宮本瞬輔, 村上暉, 西江瑠璃, 上田尚子, 橋田宗祐, 寺田信一, 古形祐平, 藤原聡枝, 田中良道, 田中智人, et al. 婦人科癌肉腫におけるPDX(Patient-Derived Xenograft)モデル. 日本婦人科腫瘍学会学術講演会プログラム・抄録集. 2022. 64回. 208-208
西江瑠璃, 田中智人, 村上暉, 上田尚子, 橋田宗祐, 宮本瞬輔, 寺田信一, 古形祐平, 藤原聡枝, 田中良道, et al. 進行婦人科癌患者における腹水・胸水を用いた患者由来がんモデルの作製と検証. 日本婦人科腫瘍学会学術講演会プログラム・抄録集. 2022. 64回. 211-211

ｍore...

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page